Clinical Trial Update: Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating nebulized magnesium sulfate for persistent pulmonary hypertension of the newborn has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Pulmonary Hypertension of the Newborn

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Sohag University | Conditions: Persistent Fetal Circulation, Persistent Pulmonary Hypertension of the Newborn | Phase 1, Phase 2 | Status: COMPLETED